Ticlopidine-induced neutropenia mimicking sepsis early after intracoronary stent placement

被引：2
|
作者：
Ochoa, AB
Wolfe, M
Lewis, P
Lenihan, DJ [1 ]
机构：
[1] Wright Patterson Med Ctr, Div Cardiol, SGOMC, Wright Patterson AFB, OH 45433 USA
[2] Wright Patterson Med Ctr, Dept Internal Med, Wright Patterson AFB, OH 45433 USA
来源：
CLINICAL CARDIOLOGY | 1998年 / 21卷 / 04期
关键词：
ticlopidine; sepsis; neutropenia; intracoronary stent;
D O I：
10.1002/clc.4960210417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a case of ticlopidine-induced profound neutropenia early in the course of therapy, which was manifest as a febrile systemic illness mimicking sepsis. This clinical presentation was potentially indicative of a contaminated intracoronary stent. The patient's signs and symptoms of illness promptly resolved with removal of ticlopidine, and no infection was documented. Review of indications for ticlopidine use, potential adverse effects, and monitoring recommendations are discussed.
引用
收藏
页码：304 / 307
页数：4
相关论文
共 8 条
  • [1] Ticlopidine-induced severe neutropenia
    Gur, H
    Wartenfeld, R
    Tanne, D
    Solomon, F
    Sidi, Y
    POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (868) : 126 - 127
  • [2] Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement
    Berger, PB
    Bell, MR
    Hasdai, D
    Grill, DE
    Melby, S
    Holmes, DR
    CIRCULATION, 1999, 99 (02) : 248 - 253
  • [3] INTRACORONARY STENT PLACEMENT IN THE RECOVERY PERIOD AFTER ACUTE MYOCARDIAL INFARCTION
    Liu Yin Gao Jing Dazhan QuChest HospitalTian jinChina
    中国介入心脏病学杂志, 1998, (04) : 158 - 158
  • [4] A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
    Ikushima, Ichiro
    Yonenaga, Kazuchika
    Iwakiri, Hironao
    Nagoshi, Hideki
    Kumagai, Haruhito
    Yamashita, Yasuyuki
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2011, 4 : 83 - 89
  • [5] Platelet and leukocyte deactivation after intracoronary stent placement in patients receiving combined antiplatelet therapy
    Atalar, E
    Aytemir, K
    Haznedaroglu, I
    Aksöyek, S
    Övünç, K
    Kirazli, S
    Özmen, F
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (02) : 116 - 121
  • [6] Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
    Peter B Berger
    Trials, 1 (2)
  • [7] Aplastic Anaemia Induced by Ticlopidine after Placement of Coronary Artery StentsTherapeutic Role of Granulocyte Colony-Stimulating Factor
    Francisca Ferrer
    Felipe De Arriba
    Jose María Moraleda
    Vicente Vicente
    Clinical Drug Investigation, 1998, 15 : 261 - 262
  • [8] Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis
    Maniscalco, Giorgia T.
    Annunziata, Mario
    Ranieri, Angelo
    Alfieri, Gennaro
    Renna, Rosaria
    Di Iorio, Walter
    Guarcello, Giovanni
    Cerillo, Ilaria
    Improta, Giovanni
    Florio, Ciro
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
1